Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Mike Karim, CEO of Oxford Endovascular outlining the state of development of its ‘origami’ flow diverter

Take a look at the interview of Mike Karim, CEO of Oxford Endovascular outlining the state of development of its ‘origami’ flow diverter for treatment of intracranial aneurysms and its future plans at the JP Morgan conference in January.

https://www.youtube.com/embed/u9poCzuK_zw …

 

Premier League footballers participate in new ground-breaking concussion study

The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (UHB) have launched a new study funded by The Drake Foundation to review and potentially enhance concussion diagnosis in Premier League football.

Read the rest of entry »

Aurelia Bioscience, a UK based CRO announces new Kinase Compound Profiling services using Promega’s NanoBRET™ technology.

Aurelia Bioscience, a UK based CRO announces new Kinase Compound Profiling services using Promega’s NanoBRET™ technology.

Read the rest of entry »

OBN Announces the Success of 2nd Annual BioSeed® 2019

Abingdon, UK, 22 January 2019: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the success of their 2nd annual BioSeed® event held on Wednesday,16 January 2019, at Level 39 in Canary Wharf, London.

Read the rest of entry »

Experimental Cell Lines Help Screening for CAR T Therapies

AMSBIO has added new experimental cell lines to its CAR T cell research range. 

Recent FDA approval of CAR T cells for treatment of leukemia and lymphoma has resulted in rapid growth in research on the therapeutic uses of such cells. The new AMSBIO experimental cell lines provide you with the power to screen antibodies and ligands against your target, enhancing your search for new CAR T therapies.

Read the rest of entry »

Absolute Antibody Receives ISO 9001:2015 Certification for Recombinant Antibody Manufacturing Facility

Oxford, UK, January 17, 2019. Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, announces its manufacturing facility based in Wilton Centre, Redcar, England has been certified under ISO 9001:2015 as of December 17, 2018.

Read the rest of entry »

RSSL introduces same-day mycoplasma testing service in UK

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines. 

Read the rest of entry »

Immunocore appoints Bahija Jallal as Chief Executive Officer

Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that Bahija Jallal has been appointed as Chief Executive Officer and Director of the Board.

Read the rest of entry »

Immunocore names David Berman as Head of R&D

Leading figure in immuno-oncology strengthens Immunocore’s senior leadership team as Immunocore names David Berman as Head of R&D. 

Read the rest of entry »

Leader in uterine monitoring closes Series A round and appoints CEO Joanna Smart to lead VivoPlex through next phase of growth

VivoPlex Group Ltd, a leader in real time and accurate intra-uterine monitoring, is pleased to announce that it has closed its Series A fundraising round at £3m.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.